Research suggests that TBI severity is linked to AD risk through neuroinflammatory reactions, amyloid-beta (Aβ) peptide accumulation, and tau protein hyperphosphorylation, which are common markers of AD pathology (26). Here, MAPT is linked to Alzheimer disease.